Dr. Rawisak Chanwat

• Thai Hepato-Biliary-Pancreatic Surgery Society (THPBS)
• Asia-Pacific Hepato-Pancreato-Biliary Association (A-PHBA)
• Laparoscopic Endoscopic Surgeons of Thailand (LEST) 
• International Association of Surgeons Gastroenterologists and Oncologists (IASGO)
• Mekong Endo-Surgery Development Association (MESDA)
• International College of Surgeons (ICS)
• Royal College of Thai Surgeons  
• Medical Council of Thailand 

Dr. Rawisak Chanwat has over 25 publications to his credit. A few among them are: 

• Sim, Y. K., Zhu, Y., Shi, L., Li, L., Chen, C. H., Kudo, M., ... & Chow, P. (2024). SAT-495 Real-World Data of Hepatocellular Carcinoma from 9 Asia-Pacific Countries (The INSIGHT Cohort): Overall survival is associated with the choice of first therapy, the number of lines of treatment, and the distance to the hospital. Journal of Hepatology, 80, S401-S402.
• Sim, Y. K., Chong, M. C., Gandhi, M., Pokharkar, Y. M., Zhu, Y., Shi, L., ... & Chow, P. K. (2023). Real-world data on the diagnosis, treatment, and management of hepatocellular carcinoma in the Asia-Pacific: The INSIGHT study. Liver Cancer.
• Aiderus, A., Seshachalam, P. V., Idzham, K., Caldez, M., Shanmugam, R., Sari, I. N., ... & Chow, P. K. H. (2023). Multi-region spatial transcriptome analysis reveals cellular networks and pathways associated with hepatocellular carcinoma recurrence. bioRxiv, 2023-07.
• Jeon, A. J., Teo, Y. Y., Sekar, K., Chong, S. L., Wu, L., Chew, S. C., ... & Chow, P. K. (2023). Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma. BMC cancer, 23(1), 118.
• Jeon, A. J., Anene-Nzelu, C. G., Teo, Y. Y., Chong, S. L., Sekar, K., Wu, L., ... & Chow, P. K. H. (2023). A genomic enhancer signature associated with hepatocellular carcinoma prognosis. JHEP Reports, 5(6), 100715.
• Prasopporn, S., Suppramote, O., Ponvilawan, B., Jamyuang, C., Chanthercrob, J., Chaiboonchoe, A., ... & Jirawatnotai, S. (2022). Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma. Frontiers in Oncology, 12, 1021632.
• Suntiparpluacha, M., Chanwat, R., Limsrichamrern, S., More-krong, P., Srifa, S., Kongsri, K., ... & Jirawatnotai, S. (2022). Establishment of cholangiocarcinoma organoids from long-term frozen tissues. Journal of Basic and Applied Pharmacology, 2(1), O11-25.
• Chan, J. J., Zhang, B., Chew, X. H., Salhi, A., Kwok, Z. H., Lim, C. Y., ... & Tay, Y. (2022). Pan-cancer pervasive upregulation of 3? UTR splicing drives tumorigenesis. Nature Cell Biology, 24(6), 928-939.